We remain open as an essential business to support our clients' needs during the fight against COVID-19.

This includes direct support of COVID-19 vaccines and therapies, formulation development and modification, small-batch manufacturing, and assistance with testing or reconfiguring products or production to support the crisis.  Learn more about our COVID-19 response.


OTC Drug Testing

Brand Equivalence to Innovation

Ensure monograph compliance to the U.S. Pharmacopoeia (USP) and European Pharmacopeia (Ph. Eur.) by partnering with Avomeen’s industry-leading OTC testing and development lab. With decades of experience in generic drug testing and bioequivalency, our talented and dedicated Ph.D. scientists are uniquely qualified to formulate improved, novel, and National Brand Equivalent (NBE) products in addition to providing indispensable analytical support.

When you’re in the OTC product development stages, get the testing you need from Avomeen’s OTC lab to guarantee you release a stable and safe product to market.

Service Specialties

Why Partner with Avomeen?

Our expert scientists will ensure your products meet cGMP and full monograph requirements, labeling under 21 CFR 201.66, and identify any contaminants or failure root causes. Here are some additional benefits from partnering with us utilizing our OTC testing services:

  • cGMP compliant, FDA registered, DEA licensed
  • Consultative, flexible, and responsive staff
  • Project customization to your specific needs
  • Experience in solving difficult analytical and formulation challenges
  • Delivery within tight timelines
  • Up-to-date regulatory knowledge to ensure compliance

Ready to Partner? So are We.

Request a quote or ask an experienced scientist today.